Posts by VIVA! Communications
Chickenpox vaccine significantly curbing childhood infection
Introduced to Australia in 2005, the chickenpox (varicella) vaccine has substantially reduced the incidence of this common childhood infection, according to a new report. Communicable Diseases Intelligence examined the impact of the chickenpox vaccine administered to children at 18 months of age. Pre- vaccine availability, Australia had an estimated 240,000 chickenpox cases each year, including…
Read MorePeter Mac streamlines cancer treatment planning with deployment of Varian solution
Varian is today (Wednesday, October 3, 2018) announcing the installation of a cloud-hosted deployment of the Varian Eclipse™ treatment planning system and Velocity™ oncology imaging informatics system across five Peter MacCallum Cancer Centre (Peter Mac) sites in Victoria, Australia. Peter Mac is one of the world’s leading cancer research, education and treatment centres. It operates…
Read MoreWorldwide recognition for GLOBALHealthPR partners
The past few weeks have seen our GLOBALHealthPR partners receiving worldwide recognition for their fantastic work in Health + Wellness PR. Last week, our agency, VIVA! Communications, was thrilled to clinch Australia’s ‘Best Public Health Initiative’ at the pharmaceutical industry’s annual PRIME Awards for our Enhancing Community Immunity Through Pharmacist-led Flu Vaccination campaign in partnership with…
Read MorePharmacy Guild of Australia & VIVA! Communications clinch Australia’s Best Public Health Initiative 2018 at PRIME Awards
Last night (September 20) Team VIVA! celebrated a huge win. Together with the Pharmacy Guild of Australia, we clinched Australia’s‘Best Public Health Initiative 2018’award for our ‘Enhancing ‘community immunity’ through pharmacist-led flu vaccinationcampaign at the pharmaceutical industry’s annual PRIME Awards. Held at The Four Seasons Hotel, Sydney, the event attracted more than 800 of the…
Read MoreACCC announces clearance of the merger of Arrow Pharmaceuticals & Apotex Australia & NZ merger
Melbourne, September 20, 2018 – The Australian Competition and Consumer Commission (ACCC) announced this morning that it ‘has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex’ after finding the transaction would not substantially lessen competition in any market. In May 2018, Strides Pharma Science Ltd and Apotex Inc. announced their…
Read More